-
Something wrong with this record ?
Carcinogenic 3-nitrobenzanthrone but not 2-nitrobenzanthrone is metabolised to an unusual mercapturic acid in rats
I. Linhart, J. Mráz, I. Hanzlíková, A. Silhánková, E. Frantík, M. Himl,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acetylcysteine urine MeSH
- Benz(a)Anthracenes chemistry pharmacokinetics urine MeSH
- Spectrometry, Mass, Electrospray Ionization MeSH
- Carcinogens chemistry metabolism MeSH
- Rats MeSH
- Air Pollutants chemistry pharmacokinetics urine MeSH
- Magnetic Resonance Spectroscopy MeSH
- Gas Chromatography-Mass Spectrometry MeSH
- Rats, Wistar MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
3-Nitrobenzanthrone (3-NBA) is an extremely potent mutagen and suspect human carcinogen found in diesel exhaust. Its isomer 2-nitrobenzanthrone (2-NBA) has also been found in ambient air. These isomers differ in mutagenicity in Salmonella by 2-3 orders of magnitude. To identify their urinary metabolites and also to assess the assumed differences in their excretion, rats were dosed orally with 2mg/kg b.w. of either 2-NBA or 3-NBA. Their urine was collected for two consecutive days after dosage. Both LC-ESI-MS and GC-MS confirmed formation of the corresponding aminobenzanthrones (ABA). Excretion of these metabolites within the first day after dosing with 2- and 3-ABA amounted to 0.32±0.06 and 0.83±0.40% of the doses, respectively, while the excretion within the second day was by one order of magnitude lower. A novel mercapturic acid metabolite of 3-NBA was identified in urine by LC-ESI-MS as N-acetyl-S-(3-aminobenzanthron-2-yl)cysteine (3-ABA-MA) by comparison with the authentic standard. Its excretion amounted to 0.49±0.15 and 0.02±0.01% of dose within the first and second day after dosing, respectively. In contrast, no mercapturic acid was detected in the urine of rats dosed with 2-NBA. Observed difference in the mercapturic acid formation between 2- and 3-NBA is a new distinctive feature reflecting differences in the critical step of their metabolism, i.e., benzanthronylnitrenium ion formation that is intrinsically associated with biological activities of these two isomers. Moreover, 3-ABA-MA is a promising candidate biomarker of exposure to the carcinogenic 3-NBA.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022592
- 003
- CZ-PrNML
- 005
- 20120903105632.0
- 007
- ta
- 008
- 120806s2012 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.toxlet.2011.11.017 $2 doi
- 035 __
- $a (PubMed)22143054
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Linhart, Igor $u Department of Organic Chemistry, Faculty of Chemical Technology, Institute of Chemical Technology, Prague, Technická 1905, CZ-166 28 Prague, Czech Republic. linharti@vscht.cz
- 245 10
- $a Carcinogenic 3-nitrobenzanthrone but not 2-nitrobenzanthrone is metabolised to an unusual mercapturic acid in rats / $c I. Linhart, J. Mráz, I. Hanzlíková, A. Silhánková, E. Frantík, M. Himl,
- 504 __
- $a $b
- 520 9_
- $a 3-Nitrobenzanthrone (3-NBA) is an extremely potent mutagen and suspect human carcinogen found in diesel exhaust. Its isomer 2-nitrobenzanthrone (2-NBA) has also been found in ambient air. These isomers differ in mutagenicity in Salmonella by 2-3 orders of magnitude. To identify their urinary metabolites and also to assess the assumed differences in their excretion, rats were dosed orally with 2mg/kg b.w. of either 2-NBA or 3-NBA. Their urine was collected for two consecutive days after dosage. Both LC-ESI-MS and GC-MS confirmed formation of the corresponding aminobenzanthrones (ABA). Excretion of these metabolites within the first day after dosing with 2- and 3-ABA amounted to 0.32±0.06 and 0.83±0.40% of the doses, respectively, while the excretion within the second day was by one order of magnitude lower. A novel mercapturic acid metabolite of 3-NBA was identified in urine by LC-ESI-MS as N-acetyl-S-(3-aminobenzanthron-2-yl)cysteine (3-ABA-MA) by comparison with the authentic standard. Its excretion amounted to 0.49±0.15 and 0.02±0.01% of dose within the first and second day after dosing, respectively. In contrast, no mercapturic acid was detected in the urine of rats dosed with 2-NBA. Observed difference in the mercapturic acid formation between 2- and 3-NBA is a new distinctive feature reflecting differences in the critical step of their metabolism, i.e., benzanthronylnitrenium ion formation that is intrinsically associated with biological activities of these two isomers. Moreover, 3-ABA-MA is a promising candidate biomarker of exposure to the carcinogenic 3-NBA.
- 650 _2
- $a acetylcystein $x moč $7 D000111
- 650 _2
- $a látky znečišťující vzduch $x chemie $x farmakokinetika $x moč $7 D000393
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benz(a)anthraceny $x chemie $x farmakokinetika $x moč $7 D001551
- 650 _2
- $a karcinogeny $x chemie $x metabolismus $7 D002273
- 650 _2
- $a plynová chromatografie s hmotnostně spektrometrickou detekcí $7 D008401
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a hmotnostní spektrometrie s elektrosprejovou ionizací $7 D021241
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mráz, Jaroslav
- 700 1_
- $a Hanzlíková, Iveta
- 700 1_
- $a Silhánková, Alexandra
- 700 1_
- $a Frantík, Emil
- 700 1_
- $a Himl, Michal
- 773 0_
- $w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 208, č. 3 (20111126), s. 246-53
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22143054 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20120903105800 $b ABA008
- 999 __
- $a ok $b bmc $g 944505 $s 779889
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 208 $c 3 $d 246-53 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a Pubmed-20120806/12/01